# Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers

> **NCT07433556** · PHASE1 · RECRUITING · sponsor: **Il-Yang Pharm. Co., Ltd.** · enrollment: 86 (estimated)

## Conditions studied

- Healhty

## Interventions

- **DRUG:** IY-828026
- **DRUG:** Placebo
- **DRUG:** IY-828026A
- **DRUG:** IY-828026B

## Key facts

- **NCT ID:** NCT07433556
- **Lead sponsor:** Il-Yang Pharm. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-23
- **Primary completion:** 2027-03
- **Final completion:** 2027-06
- **Target enrollment:** 86 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07433556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07433556, "Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07433556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*